Thermo Fisher Scientific

Open: 554.0 Close: 547.33 Change: -6.67

Don't invest in Thermo Fisher Scientific before reading this automated analysis produce by an AI.

This document will help you to evaluate Thermo Fisher Scientific without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Thermo Fisher Scientific are: Thermo, Fisher, Scientific, company, stock, …

Concept Map

Semantic Network

Stock Summary

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical.

Today's Summary

Thermo Fisher Scientific ( NYSE:TMO – Get Free Report ) last issued its quarterly earnings data on October 25th. The firm also recently declared a quarterly dividend, which was paid on January 16th.

Today's News

Barclays downgrades the U.S.-based life sciences companies, arguing that their stocks have little room for upside after the recent surge in their share prices. Thermo Fisher Scientific has pledged to stop selling forensic technology and equipment in Tibet that could be used for identifying individuals. Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it has entered into a strategic collaboration agreement with Thermo. Thermo Fisher Scientific was formed through the merger of Thermo Electron and Fisher Scientific in 2006. The company has offices and operations worldwide, notably in the U.S. Thermo Fisher Scientific received emergency use authorization from the FDA for a test for SARS-CoV-2 to help mitigate the COVID-19 pandemic. In February 2019, Thermo announced that it would stop selling equipment in Xinjiang. Thermo Fisher Scientific stock market has been down 19% in 2023 so far. The company is a scientific instrument maker. Thermo Fisher Scientific ( NYSE:TMO – Get Free Report ) last issued its quarterly earnings data on Wednesday, October 25th. The firm also recently declared a quarterly dividend, which was paid on January 16th. Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. Newsweek named Thermo Fisher Scientific one of Americas Most Responsible Companies for 2024. Thermo Fisher Scientific (NYSE:TMO) Shares Gap Up to $538.21 and its two-hundred day moving average price is $513.16. The company recently disclosed a quarterly dividend, which was paid on Tuesday, January 16th. The stock has an average rating of “Moderate Buy” and an average price target. Capillary electrophoresis in cancer research today: Join this two-part webinar to learn how capillary electrophoresi complements sequencing technologies, such as next generation sequencing, that are being used by cancer res... In this webinar, Victoria Quiett of Thermo Fisher Scientific will dive into a comprehensive look at key components of running Pharmacogenomics (PGx) in your lab. The Journey from Neanderthal DNA to a Nobel Prize: How Dynabeads... Biotechnology has spurred countless innovations in medicine. Digital PCR basics, real time PCR for molecular detection and research of infectious diseases. Synthetic DNA oligonucleotides are used broadly across many different application areas. Guardians of Your Science, Ask the Expert Webinar Series will be on May 24, 2022. Learn how to maximize KingFisher instruments to automate DNA. Streamline your path from immunodiagnostic. 222 Learning Objectives 222 222 222 223 222 222 Webinars will be available for unlimited on-demand viewing after live event. Research focused on SARS-CoV-2 has become a primary focus in genomic and molecular biology fields. Next-generation sequencing (NGS) is quickly becoming the go-to tool for testing labs looking to bring on additional clinically relevant tests requ... Thermo Fisher Scientific Inc. - Consensus ‘buy rating and 2.1% Upside Potential Thermo fisher scientific inc. - consensus buy rating and 3.0% upside potential. Thermo is closing its site in Petaluma, Calif., and will part with the facility. Thermo Fisher Scientific receives GMP approval from Italian Medicines Agency for its Manufacturing facility of RNA-Based Products in Monza, Italy. The approval and associated certification support increased accessibility to novel therapies for patients.

Stock Profile

"Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, laboratory chemicals, research and safety market channel, and pharma services and clinical research. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts."

Keywords

The game is changing. There is a new strategy to evaluate Thermo Fisher Scientific fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Thermo Fisher Scientific are: Thermo, Fisher, Scientific, company, stock, price, use, and the most common words in the summary are: fisher, scientific, thermo, omnic, issue, new, stock, . One of the sentences in the summary was: Thermo Fisher Scientific ( NYSE:TMO – Get Free Report ) last issued its quarterly earnings data on October 25th. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #fisher #scientific #thermo #omnic #issue #new #stock.